Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
PS-341 in Treating Patients With Advanced Cancer
This study is ongoing, but not recruiting participants.
Study NCT00006362 Information provided by National Cancer Institute (NCI)
First Received: October 4, 2000 Last Updated: November 16, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Leukemia
Lymphoma
Precancerous/Nonmalignant Condition
Additional conditions recognized in this trial
Lymphoproliferative Disorders
Multiple Myeloma
Neoplasms
Neoplasms, Plasma Cell
Precancerous Conditions
More general conditions related to this trial
Blood Protein Disorders
Cardiovascular Diseases
Hematologic Diseases
Hemorrhagic Disorders
Hemostatic Disorders
Immune System Diseases
Immunoproliferative Disorders
Lymphatic Diseases
Neoplasms by Histologic Type
Paraproteinemias
Vascular Diseases
Interventions listed in this trial
bortezomib
More general drug interventions related to this trial
Antineoplastic Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Protease Inhibitors
Therapeutic Uses
Sponsors listed in this trial
Mayo Clinic
National Cancer Institute (NCI)
Back to top of Main Content
